Given that RTK coactivation plays an important role in tumor response to targeted therapy (19,29,34), we sought to use molecular imaging to understand and assess the interplay between, and the dynamics of, MET, EGFR, and HER2. This evidence concerns the gene EGFR and neoplasm.